Scarica l'app Stockscreener
1.51
4.14%
0.06
Precedente Chiudi:
$1.45
Aprire:
$1.44
Volume 24 ore:
834.83K
Relative Volume:
3.77
Capitalizzazione di mercato:
$72.94M
Reddito:
-
Utile/perdita netta:
$-90.97M
Rapporto P/E:
-0.8016
EPS:
-1.8837
Flusso di cassa netto:
$-32.83M
1 W Prestazione:
-6.21%
1M Prestazione:
-12.21%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.44
$1.58
Intervallo di 1 settimana:
$1.39
$1.63
Portata 52W:
$1.39
$2.0901
Filana Therapeutics Inc Stock (FLNA) Company Profile
Nome
Filana Therapeutics Inc
Settore
Industria
Telefono
512-501-2444
Indirizzo
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN
Compare FLNA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FLNA
Filana Therapeutics Inc
|
1.51 | 72.94M | 0 | -90.97M | -32.83M | -1.8837 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Filana Therapeutics Inc Stock (FLNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-27 | Iniziato | B. Riley Securities | Buy |
| 2021-02-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-09-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | Downgrade | Maxim Group | Buy → Hold |
| 2020-01-10 | Reiterato | Maxim Group | Buy |
Mostra tutto
Filana Therapeutics Inc Borsa (FLNA) Ultime notizie
MSN Money - MSN
[ARS] FILANA THERAPEUTICS, INC. SEC Filing - Stock Titan
Filana Therapeutics (FLNA) details 2026 meeting and equity plan vote - Stock Titan
Filana Therapeutics (FLNA) director O’Donnell to leave board after 2026 meeting - Stock Titan
FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart - MEXC
Is Filana Therapeutics (FLNA) stock appealing for long-term investors (Slight Rise) 2026-04-20Continuation Pattern - Xã Châu Thành
FLNA Filana Therapeutics reports narrower Q3 2025 loss than expected, shares rise 1.45 percent in today’s session.Hot Market Picks - Newser
symbol__ Stock Quote Price and Forecast - CNN
Is Filana Therapeutics (FLNA) stock a buy today (Bearish Momentum) 2026-04-18Stock Trading Network - Newser
FLNA | Filana Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
FLNA Stock Price, News & Analysis - Stock Titan
Filana Therapeutics publishes simufilam preclinical data - TipRanks
Filana Therapeutics Publishes Study Highlighting Simufilam's Potential to Attenuate Seizure Progression in Tuberous Sclerosis Complex Model - Quiver Quantitative
In severe epilepsy mouse model, Filana drug slowed seizure worsening - Stock Titan
FLNA Options Chain — NASDAQ:FLNA - TradingView
FLNA Options Volatility — NASDAQ:FLNA - TradingView
Filana Therapeutics Inc Live Share Prices and Trades. FLNA.US Live Streaming Share Prices. - London South East
Filana Therapeutics Inc Share Price (FLNA.US) - London South East
What is the valuation of Filana Therapeutics (FLNA) Stock | Price at $1.70, Up 1.50%Pre Earnings - Newser
Is Filana Therapeutics (FLNA) Stock Near Resistance | Price at $1.68, Down 2.89%Elite Alerts - Newser
Issuance/retirement of stock (net) of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Should I Buy - Intellectia AI
Filana Therapeutics, Inc. (FLNA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Capital expenditures of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Free cash flow per share of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView — Track All Markets
Price to book ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc. Balance Sheet – NASDAQ:FLNA - TradingView
Long term debt to total equity ratio of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
EBIT of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Number of shareholders of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | FLNA * | US14817C1071 - marketscreener.com
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | PX91 | US14817C1071 - marketscreener.com
Changes in working capital of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | FLNA | US14817C1071 - marketscreener.com
Non-controlling/minority interest of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Taxes of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Technical Analysis & Stock Price Forecast - Intellectia AI
Filana Therapeutics (FLNA) Stock Analysis Report | Financials & Insights - Benzinga
Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Cassava Sciences, Inc. Class Action: The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | PX91 | US14817C1071 - marketscreener.com
Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com
Filana Therapeutics Inc (FLNA-Q) Profile - The Globe and Mail
Filana Therapeutics Inc FLNA-Q Earnings - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Insider Trade Summaries - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Stock Price and News - The Globe and Mail
Filana Therapeutics Inc (FLNA-Q) Statistics - The Globe and Mail
Net income before discontinued operations of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Total liabilities & shareholders' equities of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com
Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | SAVA * | US14817C1071 - marketscreener.com
Filana Therapeutics Inc Azioni (FLNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Filana Therapeutics Inc Azioni (FLNA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Barry Richard | President & CEO |
Nov 20 '25 |
Buy |
2.76 |
150,000 |
414,000 |
938,060 |
| Barry Richard | President & CEO |
Nov 19 '25 |
Buy |
2.75 |
73,385 |
201,809 |
788,060 |
| Cook Robert Christopher | Chief Operating & Legal Office |
Sep 30 '25 |
Buy |
2.91 |
13,725 |
39,940 |
13,725 |
| Barry Richard | President & CEO |
Sep 22 '25 |
Buy |
2.28 |
7,172 |
16,352 |
714,675 |
| Barry Richard | President & CEO |
Sep 18 '25 |
Buy |
2.24 |
190,633 |
426,424 |
660,195 |
| Barry Richard | President & CEO |
Sep 19 '25 |
Buy |
2.29 |
47,308 |
108,319 |
707,503 |
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):